Research Paper Volume 16, Issue 7 pp 6135—6146
Lifibrate attenuates blood-brain barrier damage following ischemic stroke via the MLCK/p-MLC/ZO-1 axis
Figure 2. Lifibrate ameliorated aggravation in blood-brain barrier (BBB) permeability in a middle cerebral artery occlusion (MCAO) mice model. Blood-brain barrier permeability was assayed by Evans blue staining (n=10, **, P<0.01 vs. vehicle group; ^^, P<0.01 vs. MCAO group).